Daratumumab in life-threatening autoimmune hemolytic anemia following hematopoietic stem cell transplantation

New-onset autoimmune hemolytic anemia (AIHA) occurs in 2% to 6% of pediatric patients post–hematopoietic stem cell transplantation (HSCT) and is a significant complication. Incomplete immune recovery following HSCT may predispose to immune dysregulation including autoimmune cytopenias. We describe a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Schuetz, Catharina, Hoenig, Manfred, Moshous, Despina, Weinstock, Christof, Castelle, Martin, Bendavid, Matthieu, Shimano, Kristin, Tolbert, Vanessa, Schulz, Ansgar S., Dvorak, Christopher C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2018
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6177653/
https://ncbi.nlm.nih.gov/pubmed/30291113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018020883
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados